• News
  • BioTech

Ligand reports 2Q revenues, announces share repurchase program

Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has reported that total revenues for the second quarter of 2014 are expected to be approximately $10.6 million.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Ligand Pharmaceuticals Inc.

Company Website

10275 Science Center Drive
San Diego, CA 92121

Subscribe Today!